Early Stage Breast Cancer Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Breast CancerBreast NeoplasmsHER2-negative Breast Cancer+8 more
QuantumLeap Healthcare Collaborative5,000 enrolled42 locationsNCT01042379
Recruiting
Not Applicable
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Breast CancerEarly Stage Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins30 enrolled1 locationNCT06536881